Olympus Creatinine Reagent
Alkaline Picrate, Colorimetry, Creatinine. 510(k) K934361, from Olympus Corp. (Lake Success, NY). Product code CGX, class 2.
As of Nov 18, 2026, K934361 is an FDA 510(k) held by Olympus Corp., substantially equivalent on Nov 16, 1993 after 69 days, with 1 recall tied to it in FDA's recall database.
- Review time: 69 days
- Recalls: 1
- Cited as a predicate by: 2 devices
Cited as a predicate
2 later 510(k) summaries name this device as a predicate- Medicon Hellas Albumin, Medicon Hellas Calcium, Medicon Hellas Creatinine, Medicon Hellas Urea Nitrogen, Medicon Hellas…K200898 · Medicon Hellas S.A · Sep 21, 2021
- Abx Pentra Creatinine 120 Cp; Abx Pentra Multical; Abx Pentra N Control; Abx Pentra P Control; Abx Pentra Urine ControlK110530 · Horiba Abx SAS · Apr 30, 2012
Recalls
Recalls FDA ties to K934361, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record| Started | Recall | Status |
|---|---|---|
| Dec 28, 2012 | Z-0958-2013Beckman Coulter is including additional information and instructions in the Creatinine (OSR6x78) IFU and Setting Sheet, relating to calibration stability and quality control frequency to assure product performance. | Terminated |
Other CGX clearances
The newest 510(k)s for the same product code; their median review was 236 days; see every CGX device- Tru Kidney Health Test Panel; Tru AnalyzerK251058 · Truvian Health · Nov 26, 2025
- Atellica® CH Creatinine_3 (Crea3)K242685 · Siemens Healthcare Diagnostics, Inc. · Dec 4, 2024
- Creatinine2K210452 · Abbott Ireland Diagnostics Division · Mar 22, 2022
Record
- Type
- Traditional
- Received
- Sep 8, 1993
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files